BridgeBio Pharma Inc

BBIO

Equity

ISIN US10806X1028 / Valor 48204826

NASDAQ (2024-11-20)

USD 23.04+2.22%

BridgeBio Pharma Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

BridgeBio Pharma Inc is a biopharmaceutical company focused on developing and commercializing innovative therapies for genetic diseases. In 2022, Sentynl Therapeutics, Inc. acquired global rights to NULIBRY and is responsible for the ongoing development and commercialization of NULIBRY in the U.S. and developing, manufacturing, and commercializing fosdenopterin globally. The company's mission is to address unmet medical needs in rare diseases by advancing a diverse pipeline of potential treatments.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-21.2%1Y

-46.0%3Y

-30.8%5Y

Performance

54.6%1Y

114%3Y

99.7%5Y

Volatility

4260 M

Market cap (USD)

756,568

Daily traded volume (Shares)

22.91 / 21.73

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Strategic Education Inc

Strategic Education Inc Valor: 42985312

Annual Return

-50%0%+50%

Risk level

110

0.70%USD 95.52

QuidelOrtho Corporation

QuidelOrtho Corporation Valor: 119356965

Annual Return

-50%0%+50%

Risk level

110

-2.85%USD 37.48

TransMedics Group Inc

TransMedics Group Inc Valor: 47361695

Annual Return

-50%0%+50%

Risk level

110

-6.90%USD 77.20

Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc Valor: 18393960

Annual Return

-50%0%+50%

Risk level

110

1.66%USD 36.12

Ensign Group Inc

Ensign Group Inc Valor: 3109721

Annual Return

-50%0%+50%

Risk level

110

0.07%USD 144.66

Krystal Biotech Inc

Krystal Biotech Inc Valor: 38026052

Annual Return

-50%0%+50%

Risk level

110

0.14%USD 178.10

Mochida Seiyaku KK

Mochida Seiyaku KK Valor: 762797

Annual Return

-50%0%+50%

Risk level

110

-1.95%JPY 3,260.00

Sotera Health Company

Sotera Health Company Valor: 57897071

Annual Return

-50%0%+50%

Risk level

110

-2.94%USD 13.21

ICU Medical Inc

ICU Medical Inc Valor: 940704

Annual Return

-50%0%+50%

Risk level

110

-1.24%USD 167.59

SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA Valor: 128964250

Annual Return

-50%0%+50%

Risk level

110

-1.35%EUR 26.32

Logos provided by Clearbit

BridgeBio Pharma Inc

BBIO

ISIN US10806X1028 / Valor 48204826

BridgeBio Pharma Inc UMushroom community rating:

BridgeBio Pharma Inc
UMushroom community rating: